Metabolomics is defined as the large scale study of all small molecules, commonly known as metabolites, within cells, biofluids, tissues or organisms. It is the study of substrates and products of metabolism. Metabolomics is an evolving field to comprehensively identify and quantify all endogenous and exogenous low-molecular-weight (<1 kDa) small metabolites in a biological system in a high-throughput manner which are influenced by both genetic and environmental factors, lifestyle factors, medication, and underlying disease. Collectively, these small molecules and their interactions within a biological system are known as the metabolome. The metabolome is downstream of the transcriptome and proteome and is considered to be complementary to genomics, transcriptomics, and proteomics. Metabolomics services include targeted and untargeted metabolomics services. Metabolomics has various applications in health and disease including drug assessment, biomarker discovery, nutrigenomics, clinical toxicology, crop breeding, etc. Mass spectrometry based metabolomics provides a useful approach for both identification of disease related metabolites in biofluids or tissue and also encompasses classification and characterization of disease or treatment-associated molecular patterns generated from metabolites.
Market Dynamics
Increasing adoption of inorganic strategies such as research collaboration, in order to provide metabolomics services by key market players is expected to drive the global metabolomics services market over the forecast period. For instance, in July 2021, Thermo Fisher Scientific Inc., a manufacturer of analytical instruments, announced that they had entered into a research collaboration with the University of California, Davis, to launch Center of Excellence in clinical metabolomics to develop new technologies and reproducible analytical techniques to support rapid, cost-effective clinical research into applications for metabolomics in precision medicine.
Key features of the study:
- This report provides an in-depth analysis of the global metabolomics services market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global metabolomics services market based on the following parameters–company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., SCIEX (Danaher), Waters Corporation, Shimadzu Corporation, Bruker, Human Metabolome Technologies Inc., LECO Corporation, Biocrates life sciences AG, Metabolon, Inc., Metabolomic Technologies Inc., PerkinElmer Inc., Analytik Jena GmbH, Creative Proteomics, Vproteomics, DNA Xperts Private Limited, MS-OMICS, metaSysX, BASF SE, BGI, Afekta Technologies Ltd., Metware Biotechnology Co.,Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global metabolomics services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global metabolomics services market
Detailed Segmentation:
- Global Metabolomics Services Market, By Service Type:
- Targeted Metabolomics Service
- Untargeted Metabolomics Service
- Global Metabolomics Services Market, By Technique:
- Detection Techniques
- Nuclear Magnetic Resonance Spectroscopy (NMR)
- Mass Spectrometry (MS)
- Separation Techniques
- Gas Chromatography (GC)
- Capillary Electrophoresis (CE)
- Liquid Chromatography (LC)
- Others (Supercritical Fluid Chromatography, Ion Mobility Spectrometry, etc.)
- Global Metabolomics Services Market, By Application:
- Drug Assessment
- Biomarker Discovery
- Nutrigenomics
- Clinical toxicology
- Others (Crop Breeding, Disease Diagnosis, etc.)
- Global Metabolomics Services Market, By End User:
- Academics and Research Labs
- Biotechnology and Pharmaceutical Companies
- Diagnostic Laboratories
- Global Metabolomics Services Market, By Region:
- North America
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country/Regions
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Thermo Fisher Scientific Inc.*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Agilent Technologies, Inc.
- SCIEX (Danaher)
- Waters Corporation
- Shimadzu Corporation
- Bruker
- Human Metabolome Technologies Inc.
- LECO Corporation
- Biocrates life sciences AG
- Metabolon, Inc.
- Metabolomic Technologies Inc.
- PerkinElmer Inc.
- Analytik Jena GmbH
- Creative Proteomics
- Vproteomics
- DNA Xperts Private Limited
- MS-OMICS
- metaSysX
- BASF SE
- BGI
- Afekta Technologies Ltd.
- Metware Biotechnology Co.,Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
